Li Wenyan, Liu Dawei, Zhang Xuan, Ding Yuan, Zhao Xiaodong
Department of Nephrology and Immunology, Children's Hospital of Chongqing Medical University, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing 400014, China.
Department of Nephrology and Immunology, Children's Hospital of Chongqing Medical University, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing 400014, China; Email:
Zhonghua Er Ke Za Zhi. 2015 Dec;53(12):925-30.
To investigate the clinical and immunological laboratory features, gene mutations, treatment and prognosis in children with Wiskott-Aldrich syndrome (WAS).
The clinical, laboratory characteristics, treatment and prognosis of 132 children with WAS, who visited Children's Hospital of Chongqing Medical University from April 2000 to June 2015, were analyzed retrospectively.
All patients were male. The median age of disease onset was 15 days and the median age at diagnosis was 10 months. Of the 132 cases, 112 had classic WAS, 20 had X-linked thrombocytopenia (XLT). The median platelet count was 23×10(9)/L. All cases had the clinical characteristics of WAS including bleeding, eczema, and being susceptible to infection. The initial symptoms include hemorrhage (75.0%) and eczema (16.7%). Twenty-one cases had autoimmune diseases and one patient had leukemia. WAS protein (WASP) expression in 115 cases were measured by flow cytometry, 88 cases were negative, in 12 cases WASP decreased, in 5 cases it was normal, 10 cases had bimodal distribution. Eighty-one kinds of mutations were found in 122 families, including eight kinds of hot-spot mutations, which were 290 C> N / 291G> N (R86C / H / L), 665 C> T (R211X), 155 C> T (R41X), 168 C> T (T45 M), IVS1+ 1 g> t/ a, IVS6 + 5 g> a, IVS8 + 1 g> a and IVS8 + 1to + 6del gtga. Meantime, 29 kinds of novel mutations were found, which were 321T>C, 415C>A, 471C>T, 102-105delC, 521 del C, 1330 del A, IVS2-2 a>c, 168 C>A/1412 C> T, exon1-2 del/1412 C>T, and so on. The proportion of CD3(+) T cells (31.3%), helper T cells (37.3%) and cytotoxic T cells (38.6%) in the peripheral blood declined. The serum levels of IgG (51.1%), IgA (43.3%) and IgE (40.0%) increased, IgM (25.6%) decreased. Of the 132 cases, 72 remain survived, of whom 36 cases received hematopoietic stem cell transplantation (HSCT), 14 patients with classic WAS received intravenous immunoglobulin (IVIG) therapy. With regular IVIG therapy, the frequency of infections was reduced and the patients' symptoms were improved.
The clinical characteristics of Wiskott-Aldrich syndrome were early age of onset, microthrombocytopenia, eczema and recurrent infections. The proportion of T lymphocyte declined, the serum levels of IgG, IgA, and IgE increased, and level of IgM decreased in a part of patients. The detection of WAS gene mutation and WAS protein detection was the key diagnostic methods. Regular IVIG can gain more time for children who will receive HSCT and improve their quality of life.
探讨维斯科特-奥尔德里奇综合征(WAS)患儿的临床及免疫实验室特征、基因突变、治疗及预后情况。
回顾性分析2000年4月至2015年6月期间在重庆医科大学附属儿童医院就诊的132例WAS患儿的临床、实验室特征、治疗及预后情况。
所有患者均为男性。发病年龄中位数为15天,诊断年龄中位数为10个月。132例中,112例为典型WAS,20例为X连锁血小板减少症(XLT)。血小板计数中位数为23×10⁹/L。所有病例均具有WAS的临床特征,包括出血、湿疹和易感染。初始症状包括出血(75.0%)和湿疹(16.7%)。21例有自身免疫性疾病,1例有白血病。采用流式细胞术检测115例患儿的WAS蛋白(WASP)表达,88例为阴性,12例WASP降低,5例正常,10例呈双峰分布。在122个家系中发现81种突变,包括8种热点突变,分别为290 C>N/291G>N(R86C/H/L)、665 C>T(R211X)、155 C>T(R41X)、168 C>T(T45M)、IVS1+1 g>t/a、IVS6+5 g>a、IVS8+1 g>a和IVS8+1至+6del gtga。同时发现29种新突变,如321T>C、415C>A、471C>T、102 - 105delC、521 del C、1330 del A、IVS2 - 2 a>c、168 C>A/1412 C>T、exon1 - 2 del/1412 C>T等。外周血中CD3⁺T细胞(31.3%)、辅助性T细胞(37.3%)和细胞毒性T细胞(38.6%)比例下降。血清IgG(51.1%)、IgA(43.3%)和IgE(40.0%)水平升高,IgM(25.6%)降低。132例中,72例存活,其中36例接受了造血干细胞移植(HSCT),14例典型WAS患者接受了静脉注射免疫球蛋白(IVIG)治疗。经规律IVIG治疗后,感染频率降低,患者症状改善。
维斯科特-奥尔德里奇综合征的临床特征为发病年龄早、血小板减少、湿疹和反复感染。部分患者T淋巴细胞比例下降,血清IgG、IgA、IgE水平升高,IgM水平降低。检测WAS基因突变和WASP蛋白是关键诊断方法。规律IVIG可为接受HSCT的患儿争取更多时间并改善其生活质量。